A5050935569- Central Venous Catheters and Hemodialysis
- Dialysis and Renal Disease Management
- Parathyroid Disorders and Treatments
- Vascular Procedures and Complications
- COVID-19 Clinical Research Studies
- Potassium and Related Disorders
- Hepatitis C virus research
- Bipolar Disorder and Treatment
- Hepatitis B Virus Studies
- SARS-CoV-2 and COVID-19 Research
- Infective Endocarditis Diagnosis and Management
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Vascular anomalies and interventions
- Acute Kidney Injury Research
- Streptococcal Infections and Treatments
- COVID-19 and healthcare impacts
- Long-Term Effects of COVID-19
- Chronic Kidney Disease and Diabetes
- Hemodynamic Monitoring and Therapy
- Kidney Stones and Urolithiasis Treatments
- Blood Pressure and Hypertension Studies
- Electrolyte and hormonal disorders
- Influenza Virus Research Studies
- Bone and Joint Diseases
- Healthcare cost, quality, practices
Cliniques Universitaires Saint-Luc
2015-2024
UCLouvain
2013-2024
Directorate-General Joint Research Centre
2020-2024
Statistics Belgium
2023
Pediatric Nephrology of Alabama
2022
RELX Group (United States)
2018-2020
eCrCl (mL/min) a Warfarin Apixaban b Dabigatran Edoxaban c Rivaroxaban >95 Adjusted dose (INR 2-3) 5 mg b.i.d.150 b.i.d.60 QD d 20 51-95 31-50 b.i.d.(eCrCl cut-off 25 mL/min) 150 b.i.d. or 110 e 30 15 INR, international normalized ratio.a Cockcroft-Gault estimated creatinine clearance (eCrCl).b modification from to 2.5 b.i.d.if patient has any two of the following: serum > _1.5 mg/dL, age _80 years, body weight < _60 kg.c In ENGAGE-AF TIMI 48 study, was halved if 30-50 mL/min, kg,...
ABSTRACT Background Finerenone, a non-steroidal mineralocorticoid receptor antagonist, improved kidney and cardiovascular outcomes in patients with chronic disease (CKD) type 2 diabetes two phase 3 outcome trials. The addition to standard of care, on the progression Non-Diabetic Chronic Kidney Disease (FIND-CKD) study investigates effect finerenone adults CKD without diabetes. Methods FIND-CKD (NCT05047263 EU CT 2023-506897-11-00) is randomized, double-blind, placebo-controlled trial...
Chapter 2. Surgical and endovascular interventions for promoting arteriovenous fistula maturation 2.1.We suggest using regional block anaesthesia rather than local creation in adults with end-stage kidney disease.(2C) 2.2.We there is insufficient evidence to support endof-vein side-of-artery over side-of-vein side-ofartery anastomosis disease (2C) peri-and postoperative care of AV fistulas grafts ii3 Downloaded from https://academic.oup.com/ndt/article/34/Supplement_2/ii1/5514502 by guest on...
Nephrology Section, Department of Internal Medicine, University Hospital, Gent, Belgium, Nephrology, Dialysis and Intensive Care Unit, Lapeyronie Montpellier, France, Renal Royal Derby Derby, UK, Cliniques Universitaires Saint-Luc, Universite Catholique de Louvain, Brussels, Department, Consorcio Hospital General Universitario, Valencia, Spain Vascular Surgery, Maastricht Medical Center, Maastricht, the Netherlands
Background. The K/DOQI guidelines recommend the use of albumin-corrected calcium (Ca), phosphate, parathyroid hormone (PTH) and calcium-phosphate product as therapeutic targets. two most common assays for measuring albumin yield discordant results in uraemic patients, Bromcresol purple (BCP) method providing lower values than green one (BCG). aim this study was to assess impact assay on corrected Ca and, thus, reaching recommended targets CaxP product.
As the worst global pandemic of past century, coronavirus disease 2019 (COVID-19) has had a disproportionate effect on maintenance dialysis patients and their health care providers. At virtual roundtable June 12, 2020, Dialysis Outcomes Practice Patterns Study (DOPPS) investigators from 15 countries in Asia, Europe, Americas described compared effects COVID-19 care, with recent updates added. Most striking is huge difference risk to staff across world. Per-population cases deaths among vary...
Cardiovascular calcifications are prevented by matrix Gla protein (MGP), a vitamin K-dependent protein. Haemodialysis patients exhibit marked K deficiency. The randomized, prospective, open-label, multicentre VitaVasK trial analysed whether K1 supplementation reduces progression of coronary artery (CACs) and thoracic aortic (TACs).Patients with pre-existing CACs were randomized to continue on standard care or additionally receive 5 mg orally thrice weekly. Hierarchically ordered primary...
IntroductionEtelcalcetide is an intravenous calcimimetic agent, effectively reducing parathyroid hormone levels in patients on maintenance hemodialysis (HD). The clinical impact of discontinuing etelcalcetide at the time kidney transplantation unknown.MethodsWe retrospectively reviewed all meeting predefined criteria who received a transplant our institution between 01/01/2015 and 12/31/2022. incidence parathyroidectomy evolution calcium, phosphate, intact PTH after was analyzed according to...
KDOQI guidelines recommend preparation for renal replacement therapy (RRT) once stage 4 chronic kidney disease (CKD) is reached. Recent studies conducted in the general population and patients referred to nephrologists have shown that CKD patients, especially elderly, are much more likely die than reach RRT. We investigated whether futile RRT was performed our nephrology department.We included all (n = 386) with without prior RRT, seen at outpatient clinic between 1 November 2004 30 April...
<b><i>Background:</i></b> Although potassium-binding sodium-based resins (K resins) have been prescribed to treat hyperkalemia for 50 years, there no large studies of their effects among hemodialysis (HD) patients. <b><i>Methods:</i></b> Data from 11,409 patients in the Dialysis Outcomes and Practice Patterns Study Belgium, Canada, France, Italy, Sweden (nations where ≥5% were a sodium- based K resin; seven other countries had <5% use)...
Although superior vena cava (SVC) stenosis may be a life-threatening complication of haemodialysis (HD) catheters, its prevalence and risk factors in HD patients are unknown. Our aim was to assess the for SVC with tunnelled cuffed catheter (TCC) describe clinical presentation.In this single-centre, retrospective cohort study, all in-centre chronic carrying TCC (1 January 2008-31 December 2012) were included (n = 117 patients, 214 TCC, 80 911 catheter-days). defined as diameter reduction >50%...
Coronavirus disease 2019 , which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), particularly life threatening in patients who are immunocompromised, including those with advanced chronic kidney (CKD) [1,2].Despite the implementation of a third dose messenger RNA (mRNA) vaccine, efficacy SARS-CoV-2 vaccination on humoral and cellular immunities reduced population CKD, resulting an increased incidence infection mortality, fully vaccinated [3].In this context,...
We describe an HIV1-positive patient under long-term tenofovir treatment who developed a severe, biopsy-proven, acute tubular necrosis with proximal tubule (PT) dysfunction, precipitated by the very recent start of diclofenac, nonsteroidal antiinflammatory drug (NSAID). Recent studies show that NSAIDs not only alter glomerular filtration but also multidrug resistance protein (MRP) 4-mediated PT secretion several substrates. Since tolerated well for years prior to diclofenac use, our...
Mutations in the UMOD gene coding for uromodulin cause autosomal dominant tubulointerstitial kidney disease. Uromodulin is known to regulate transport processes thick ascending limb, but it remains unknown whether mutations are associated with functional tubular alterations early phase of The responses furosemide and a water deprivation test were compared 32-year-old female patient carrying pathogenic mutation p.C217G her unaffected 31-year-old sister. A single dose induced an intense...
Purpose The purpose of this study is to explore how vascular access care was reimbursed, promoted, and organised at the national level in European neighbouring countries. Methods An electronic survey among experts collect country-level data. Results Forty-seven (response rate, 76%) from 37 countries participated. Experts 23 reported that 50% or less patients received routine pre-operative imaging vessels. Nephrologists placed catheters created fistulas 26 8 countries, respectively....
Background. The 2009 pandemic of influenza A (H1N1) prompted an urgent worldwide vaccination campaign, especially high-risk subjects, such as maintenance haemodialysis (HD) patients. Still the immunogenicity vaccine in HD patients is unknown.
Infective endocarditis (IE) and small-vessel vasculitis may have similar clinical features, including glomerulonephritis. Furthermore the association between IE ANCA positivity is well documented, making differential diagnosis IE- ANCA-associated particularly difficult, especially in case of culture-negative IE. We report on one patient with glomerulonephritis secondary to caused by Bartonella henselae which illustrates this diagnostic difficulty.